Aurinia Pharmaceuticals Inc.·4

Mar 3, 4:12 PM ET

Robertson Stephen P. 4

4 · Aurinia Pharmaceuticals Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-02-27
Robertson Stephen P.
EVP, General Counsel
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-27+59,090542,386 total
  • Tax Payment

    Common Stock

    [F2]
    2026-03-02$14.21/sh36,525$519,020505,861 total
  • Award

    Employee Stock Option (right to buy)

    [F3]
    2026-02-27+98,81398,813 total
    Exercise: $13.97Exp: 2036-02-27Common Stock (98,813 underlying)
Footnotes (3)
  • [F1]Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.
  • [F2]Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.
  • [F3]One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
Signature
/s/ Stephen P. Robertson|2026-03-03

Documents

1 file
  • 4
    wk-form4_1772572374.xmlPrimary

    FORM 4